Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionBlume Capital Management, Inc.
Latest Disclosed Ownership530 shares
Latest Disclosed Value $ 186,481
Blume Capital Management, Inc. ownership in AMGN / Amgen Inc.

On May 1, 2026 - Blume Capital Management, Inc. filed a 13F-HR form disclosing ownership of 530 shares of Amgen Inc. (CH:AMGN) valued at $186,481 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 530 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F AMGEN COM 031162100 530 0 0.00 186 7.51 0.0317
2026-02-05 2025-12-31 13F AMGEN COM 031162100 530 0 0.00 173 16.11 0.0316
2025-11-06 2025-09-30 13F AMGEN COM 031162100 530 0 0.00 150 1.36 0.0284
2025-07-30 2025-06-30 13F AMGEN COM 031162100 530 -2 -0.38 148 -10.91 0.0298
2025-05-06 2025-03-31 13F AMGEN COM 031162100 532 2 0.38 166 19.57 0.0371
2025-02-10 2024-12-31 13F AMGEN COM 031162100 530 0 0.00 138 -18.82 0.0309
2024-10-29 2024-09-30 13F AMGEN COM 031162100 530 -25 -4.50 171 -1.73 0.0382
2024-08-05 2024-06-30 13F AMGEN COM 031162100 555 0 0.00 173 10.19 0.0418
2024-05-02 2024-03-31 13F AMGEN COM 031162100 555 0 0.00 158 -1.26 0.0381
2024-05-02 2023-12-31 13F/A-1 AMGEN COM 031162100 555 0 0.00 160 6.71 0.0418
2024-02-07 2023-12-31 13F AMGEN COM 031162100 555 0 160 0.0418
2024-05-02 2023-09-30 13F/A-1 AMGEN COM 031162100 555 0 0.00 149 21.14 0.0441
2023-11-03 2023-09-30 13F AMGEN COM 031162100 555 0 149 0.0441
2024-05-02 2023-06-30 13F/A-1 AMGEN COM 031162100 555 0 0.00 123 -8.21 0.0361
2023-08-10 2023-06-30 13F AMGEN COM 031162100 555 0 123 0.0361
2024-05-02 2023-03-31 13F/A-1 Amgen COM 031162100 555 0 0.00 134 -7.59 0.0425
2023-05-08 2023-03-31 13F Amgen COM 031162100 555 0 134 0.0425
2023-02-08 2022-12-31 13F Amgen COM 031162100 555 0 0.00 146 16.00 0.0492
2022-11-15 2022-09-30 13F AMGEN COM 031162100 555 -3 -0.54 125 -8.09 0.0471
2022-08-11 2022-06-30 13F AMGEN COM 031162100 558 36 6.90 136 7.94 0.0537
2022-05-12 2022-03-31 13F Amgen COM 031162100 522 0 0.00 126 7.69 0.0416
2022-02-07 2021-12-31 13F Amgen COM 031162100 522 0 0.00 117 5.41 0.0386
2021-11-12 2021-09-30 13F Amgen COM 031162100 522 0 0.00 111 -12.60 0.0406
2021-08-10 2021-06-30 13F Amgen COM 031162100 522 0 0.00 127 -2.31 0.0465
2021-05-10 2021-03-31 13F Amgen COM 031162100 522 122 30.50 130 41.30 0.0512
2021-02-09 2020-12-31 13F Amgen COM 031162100 400 0 0.00 92 -9.80 0.0394
2020-11-12 2020-09-30 13F Amgen COM 031162100 400 0 0.00 102 8.51 0.0517
2020-08-06 2020-06-30 13F Amgen COM 031162100 400 0 0.00 94 16.05 0.0521
2020-05-07 2020-03-31 13F Amgen COM 031162100 400 0 0.00 81 -15.62 0.0519
2020-02-05 2019-12-31 13F Amgen COM 031162100 400 0 0.00 96 24.68 0.0470
2019-11-12 2019-09-30 13F Amgen COM 031162100 400 0 0.00 77 4.05 0.0385
2019-07-29 2019-06-30 13F Amgen COM 031162100 400 0 0.00 74 -2.63 0.0375
2019-05-06 2019-03-31 13F Amgen COM 031162100 400 0 0.00 76 -2.56 0.0399
2019-02-05 2018-12-31 13F Amgen COM 031162100 400 0 0.00 78 -6.02 0.0445
2018-11-02 2018-09-30 13F Amgen COM 031162100 400 0 0.00 83 12.16 0.0434
2018-08-02 2018-06-30 13F Amgen COM 031162100 400 0 0.00 74 8.82 0.0404
2018-05-04 2018-03-31 13F Amgen COM 031162100 400 0 0.00 68 -2.86 0.0378
2018-02-09 2017-12-31 13F Amgen COM 031162100 400 0 0.00 70 -6.67 0.0358
2018-02-14 2017-09-30 13F/A-1 Amgen COM 031162100 400 0 0.00 75 8.70 0.0397
2017-11-13 2017-09-30 13F Amgen COM 031162100 400 0 75
2017-08-08 2017-06-30 13F Amgen COM 031162100 400 0 0.00 69 4.55 0.0392
2017-05-12 2017-03-31 13F Amgen COM 031162100 400 0 0.00 66 13.79 0.0382
2017-01-30 2016-12-31 13F Amgen COM 031162100 400 -25 -5.88 58 -18.31 0.0349
2016-11-07 2016-09-30 13F Amgen COM 031162100 425 0 0.00 71 9.23 0.0435
2016-08-11 2016-06-30 13F/A-1 Amgen COM 031162100 425 0 0.00 65 1.56 0.0429
2016-08-04 2016-06-30 13F Amgen COM 031162100 25 65
2016-05-12 2016-03-31 13F Amgen COM 031162100 425 25 6.25 64 -1.54 0.0442
2016-05-26 2015-12-31 13F/A-1 Amgen COM 031162100 400 0 0.00 65 18.18 0.0460
2016-02-08 2015-12-31 13F AMGEN COM 031162100 400 65
2015-11-05 2015-09-30 13F AMGEN COM 031162100 400 -100 -20.00 55 -28.57 0.0446
2015-08-11 2015-06-30 13F AMGEN COM 031162100 500 -736 -59.55 77 -61.11 0.0583
2015-05-05 2015-03-31 13F AMGEN COM 031162100 1,236 300 32.05 198 32.89 0.1373
2015-02-10 2014-12-31 13F AMGEN COM 031162100 936 436 87.20 149 112.86 0.1050
2014-11-12 2014-09-30 13F AMGEN COM 031162100 500 0 0.00 70 18.64 0.0545
2014-07-29 2014-06-30 13F AMGEN COM 031162100 500 0 0.00 59 -4.84 0.0463
2014-05-13 2014-03-31 13F AMGEN COM 031162100 500 0 0.00 62 8.77 0.0492
2014-02-14 2013-12-31 13F AMGEN COM 031162100 500 500 57 0.0471
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.